Skip Navigation

Family Planning: A Global Handbook for Providers

Go to Family Planning Handbook Home page

Family Planning

A GLOBAL HANDBOOK FOR PROVIDERS

    = Use the method
 
    = Do not use the method
 
I   = Initiation of the method
 
C   = Continuation of the method
 
  = Use the method
 
NA   = Not applicable

Condition

Combined oral contraceptives Monthly injectables Combined patch and combined vaginal ring Progestin-only pills Progestin-only injectables Implants Emergency contraceptive pills* Copper-bearing intrauterine device Levonorgestrel intrauterine device Female sterilization*
PERSONAL CHARACTERISTICS AND REPRODUCTIVE HISTORY
Pregnant NA NA NA NA NA NA NA 4 4 D
Age Menarche to
< 40 years
Menarche to
< 18 years
Menarche
to <20
years
Young
age
1 1 1 1 2 1 2 2 C
≥ 40 years 18 to 45 years ≥ 20 years  
2 2 2 1 1 1 1 1  
  > 45   
  1 2 1  
Parity  
Nulliparous (has not
given birth)
1 1 1 1 1 1 2 2 A
Parous (has given birth) 1 1 1 1 1 1 1 1 A
Breastfeeding  
< 6 weeks postpartum 4 4 4 3a 3a 3a 1 b b *
≥ 6 weeks to < 6 months postpartum (primarily breastfeeding) 3 3 3 1 1 1 1 b b A
≥ 6 months postpartum 2 2 2 1 1 1 1 b b A
Postpartum
(not breastfeeding)
 
< 21 days 3 3 3 1 1 1 b b *
With other added VTE risk factors 3/4** 3/4** 3/4**
21–42 days 2 2 2 1 1 1 b b *
With other added VTE risk factors 2/3** 2/3** 2/3**
>42 days 1 1 1 1 1 1 1 1 A
Postabortion  
First trimester 1 1 1 1 1 1 1 1 *
Second trimester 1 1 1 1 1 1 2 2
Immediate post-septic abortion 1 1 1 1 1 1 4 4
Past ectopic pregnancy 1 1 1 2 1 1 1 1 1 A
History of pelvic surgery 1 1 1 1 1 1 1 1 C*
Smoking  
Age < 35 years 2 2 2 1 1 1 1 1 A
Age ≥ 35 years  
<15 cigarettes/day 3 2 3 1 1 1 1 1 A
≥15 cigarettes/day 4 3 4 1 1 1 1 1 A
Obesity  
≥ 30 kg/m² body mass index 2 2 2 1 1 1 1 1 C
Blood pressure measurement unavailable NAc NAc NAc NAc NAc NAc NA NA NA

* See additional conditions relating to emergency contraceptive pills and female sterilization.

** Category depends on the number, severity, and combination of risk factors for VTE.

a In settings where pregnancy morbidity and mortality risks are high and this method is one of few widely available contraceptives, it may be made accessible to breastfeeding women immediately postpartum.

b Postpartum IUD use: For the copper-bearing IUD, insertion at <48 hours is category 1. For the LNG-IUD, insertion at <48 hours is category 3 for breastfeeding women and category 1 for women not breastfeeding. For all women and both IUD types, insertion from 48 hours to <4 weeks is category 3; >4 weeks, category 1; and puerperal sepsis, category 4.

From menarche to age <18 years, ≥30 kg/m2 body mass index is category 2 for DMPA, category 1 for NET-EN.

 c In settings where pregnancy morbidity and mortality risks are high and this method is one of few widely available contraceptives, women should not be denied access simply because their blood pressure cannot be measured.